India  

Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India

DNA Tuesday, 1 December 2020
Dr Reddy's and RDIF had entered into a partnership to conduct clinical trials and rights for distribution of the first 100 million doses in India.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Covid vaccine: 'Never said all Indians to be vaccinated,' says Union govt

Covid vaccine: 'Never said all Indians to be vaccinated,' says Union govt 02:36

The Union government claimed that it never spoke of vaccinating the entire Indian population. Union Health Secretary Rajesh Bhushan made the comment while addressing a press briefing on the Covid-19 pandemic. Indian Council of Medical Research Director-General Balram Bhargava elaborated on the...

💡 newsR Knowledge: Other News Mentions

Sputnik V COVID-19 vaccine Sputnik V COVID-19 vaccine Viral vector vaccine based on human adenovirus

Russian trials show Sputnik V vaccine performs well against COVID variants

Russia's Sputnik V vaccine has produced strong results against new COVID-19 mutations in recent trials, researchers claim.
Sky News
Which vaccine should I choose? Serbia gives citizens choice of four coronavirus jabs [Video]

Which vaccine should I choose? Serbia gives citizens choice of four coronavirus jabs

Which would you prefer? In Serbia, people can select any of four jabs: the one developed by Pfizer-BioNTech, China’s Sinopharm, Russia’s Sputnik V and Oxford-Astrazeneca's.

Credit: Euronews English    Duration: 01:53Published
Exclusive: Inside Russia's new Covid-19 vaccine factory [Video]

Exclusive: Inside Russia's new Covid-19 vaccine factory

In a CNN exclusive interview, Matthew Chance takes us inside Russia’s new coronavirus vaccine factory, where manufacturers are producing coronavirus vaccine Sputnik V.

Credit: Bleacher Report AOL    Duration: 03:21Published
Lithuanian FM: Russia 'absolutely' playing politics with its vaccine [Video]

Lithuanian FM: Russia 'absolutely' playing politics with its vaccine

CNN’s Becky Anderson speaks with Lithuanian Foreign Minister Gabrielius Landsbergis about why he says Russia is using its Sputnik V coronavirus vaccine to score geopolitical points.

Credit: Bleacher Report AOL    Duration: 02:57Published

You Might Like


Related videos from verified sources

China's Sinopharm says its Covid-19 vaccine is 79% effective [Video]

China's Sinopharm says its Covid-19 vaccine is 79% effective

China’s state-owned pharmaceutical giant Sinopharm has announced its coronavirus vaccine is 79.34% effective. Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who..

Credit: Bleacher Report AOL     Duration: 01:41Published
Vaccine trial participant 'proud' of involvement as Oxford jab approved [Video]

Vaccine trial participant 'proud' of involvement as Oxford jab approved

Jack Sommers, who was part of the clinical trials for the Covid-19 vaccinefrom Oxford University and AstraZeneca, said he was proud after it was giventhe green light on Wednesday morning.

Credit: PA - Press Association STUDIO     Duration: 00:41Published
‘Doctors, nurses are real Superman & Wonder Woman’: Rajnath Singh [Video]

‘Doctors, nurses are real Superman & Wonder Woman’: Rajnath Singh

Defence Minister Rajnath Singh lauded the medical fraternity for their service during the Covid-19 pandemic. While speaking at the convocation of Lucknow's King George Medical University via video..

Credit: HT Digital Content     Duration: 02:25Published

Related news from verified sources

Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India

Dr Reddy's and RDIF had entered into a partnership to conduct clinical trials and rights for distribution of the first 100 million doses in India.
DNA Also reported by •IndiaTimes

Sputnik V from Russia arrives in India for clinal trials

Sputnik V, the first registered Covid-19 vaccine from Russia arrived in India on Tuesday for clinical trials. Russian Direct Investment Fund (RDIF) and Dr...
Mid-Day